|
|
|
Real Estate News Releases
|
(EMAILWIRE.COM, February 29, 2012 ) Belize City, Belize -- Publishers of daily newsletter xtremepicks.com (http://www.xtremepicks.com) looks Cannabis Science (CBIS) and FUSE Science (DROP):
DROP is becoming one of the best valued long term play that already gave members 83,000% gains from xtremepicks initial sub-penny alert of $0.0015 reaching a high of $1.25. With today’s news, it strengthens DROP‘s position in the main event of Sports energy drinks and recovery solutions.
Fuse Science Announces Licensing and Distribution Agreements with Mission Product Holdings, Inc.
Fuse Science Inc (OTCQB: DROP.PK – News), (www.fusescience.com), announced today that it has entered into licensing and distribution agreements with Mission Product Holdings, Inc., the parent company of Mission Athletecare™ (www.missionathletecare.com), to facilitate consumer access to Fuse Science’s unique medicine and nutrient delivery technology.
DROP close at $0.39 up 21% breaking through several short term resistance points and poised for a major breakout this week.
DROP Chart
DROP is definitely a solid value play. Confirming a double bottom and establishing a level where value investors now sees DROP at a prime price level to establish a position.
Definition of ‘Value Investing’
The strategy of selecting stocks that trade for less than their intrinsic values. Value investors actively seek stocks of companies that they believe the market has undervalued. They believe the market overreacts to good and bad news, resulting in stock price movements that do not correspond with the companyÂ’s long-term fundamentals. The result is an opportunity for value investors to profit by buying when the price is deflated.
Xtremepicks definitely see a solid buying opportunity here for DROP, establishing a solid support level as indicated in the double bottom formation, low RSI value, and undervalued MACD line.
About FUSE Science
Fuse Science Inc. is a company made from leading scientific minds and consumer product industry experts with a common goal to raise the standard of product performance through science in key multi-billion dollar categories. We leverage our global leading science to completely change the rules of the game. WeÂ’ve discovered through a combination of pending patents and trade secrets that we can now encapsulate nutrients, actives and other molecules at a far greater concentration than any time in historyÂ… What use to require consuming an 8 oz energy drink can be done with safer formulations and faster results in a single drop.
Fuse Science breakthroughs can deliver Energy, Nutrition, Medication, Skin Care and an endless number of other products with faster absorption, quicker results and better efficacy.
http://www.cannabisscience.com/templates/rt_metamorph_j15/images/style1/logo.png
http://www.cannabisscience.com/templates/rt_metamorph_j15/images/blank.gif
CANNABIS SCIENCE
CBIS morning press release gave a big boost right out of the gates hitting prices back to double digit prixtremepicks initial alert at $0.04!
With sucessful initial trials, many investors are taking notice of CBIS and a potential winner to fight against ailments.
Cancer Drug Market Evolves – Cannabis Science and ARIAD Pharmaceuticals Poised to Benefit
The Paragon Report examines investing opportunities in the Healthcare sector and provides equity research on Cannabis Science Inc. (OTC.BB: CBIS.OB – News). Access to the full company reports can be found at:
www.paragonreport.com/CBIS
CBIS closed at $0.11 on monster volume of 45 Million shares traded – investors bet there are a lot of eyes on CBIS and much higher prices will soon follow.
CBIS Chart
About Cannabis Science, Inc.
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.
The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.
About Xtremepicks.com
Xtremepicks.com team of excellence strives to find undervalued, good momentum stock plays. Xtremepicks.com provide market awareness services for small to mid-cap stocks with daily and special newsletters to keep you informed of the latest movers.
Xtremepicks.com penny stock newsletter is your trading connection and remember to always do your own research, use stop loss orders to protect yourself, and book your profits when in a position to do so.
Xtremepicks.com penny stock newsletter profiles are not a solicitation or recommendation to buy, sell or hold securities and is not offering securities for sale. Verify all claims and do your own due diligence. . Xtremepicks received no compensation for DROP and CBIS and may be buyers in the open market. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved
Directglobalmedia.com
Max Gordon
6479227508
contact@directglobalmedia.com 
|
|
|
|
Real Estate News by Sector
|
|
|
|
|
